Home
>
National Drug Code (NDC)
>
Menveo
Menveo - 46028-208-01 - (Meningococcal (Groups A, C, W-135 and Y) CRM197 Oligosaccharide Conjugate Vaccine)
Drug Information of Menveo
| Product NDC: | 46028-208 |
| Proprietary Name: | Menveo |
| Non Proprietary Name: | Meningococcal (Groups A, C, W-135 and Y) CRM197 Oligosaccharide Conjugate Vaccine |
| Active Ingredient(s): | & nbsp; Meningococcal (Groups A, C, W-135 and Y) CRM197 Oligosaccharide Conjugate Vaccine |
| Administration Route(s): | INTRAMUSCULAR |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Menveo
| Product NDC: | 46028-208 |
| Labeler Name: | Novartis Vaccines and Diagnostics s.r.l. |
| Product Type: | VACCINE |
| FDA Application Number: | BLA125300 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20100225 |
Package Information of Menveo
| Package NDC: | 46028-208-01 |
| Package Description: | 5 KIT in 1 PACKAGE (46028-208-01) > 1 KIT in 1 KIT * .5 mL in 1 VIAL, SINGLE-DOSE * .5 mL in 1 VIAL, SINGLE-DOSE |
NDC Information of Menveo
| NDC Code | 46028-208-01 |
| Proprietary Name | Menveo |
| Package Description | 5 KIT in 1 PACKAGE (46028-208-01) > 1 KIT in 1 KIT * .5 mL in 1 VIAL, SINGLE-DOSE * .5 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 46028-208 |
| Product Type Name | VACCINE |
| Non Proprietary Name | Meningococcal (Groups A, C, W-135 and Y) CRM197 Oligosaccharide Conjugate Vaccine |
| Dosage Form Name | KIT |
| Route Name | INTRAMUSCULAR |
| Start Marketing Date | 20100225 |
| Marketing Category Name | BLA |
| Labeler Name | Novartis Vaccines and Diagnostics s.r.l. |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |
